{
    "nctId": "NCT05305963",
    "briefTitle": "Breast CANcer Risk Assessment in Younger Women: BCAN-RAY",
    "officialTitle": "A Case Control Study of Women Aged 30-39 to Augment Breast Cancer Risk Prediction and Assess Acceptability and Preference of a Systematic Risk Prediction Approach Through Primary Care",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "Mammographic Density and Risk",
    "eligibilityCriteria": "4.1 Inclusion Criteria 4.1.1 Main study\n\nThe following criteria must be met for entry to the main case control study:\n\n4.1.1.1 Cases\n\n* Born biologically female\n* Aged 30-39 years when diagnosed with breast cancer\n* Able to provide informed consent\n\n4.1.1.2 Controls\n\n* Born biologically female\n* Aged 30-39 years\n* Able to provide informed consent\n\n4.1.2 Acceptability Substudy All control participants that are eligible for the main study are eligible for inclusion in the acceptability substudy.\n\n4.1.3 DNA methylation substudy\n\nCase participants will only be eligible for the DNAme substudy if they fulfill all eligibility criteria for the main study and the following inclusion criterion:\n\n\u2022 Yet to receive any systemic therapy for early breast cancer (chemotherapy, endocrine therapy or targeted therapy eg trastuzumab (Herceptin))\n\nAll control participants are eligible for the DNAme substudy if eligibility criteria are met for the main study.",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT"
}